Bristol-Myers Squibb to Announce Results for Second Quarter 2018 on July 26
Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com or by dialing in the U.S. toll free 323-794-2093 or international 866-548-4713, confirmation code: 4235170. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 1:30 p.m. EDT on July 26 through 1:30 p.m. EDT on, August 9, 2018. The replay will also be available through http://investor.bms.com or by dialing in the U.S. toll free 888-203-1112 or international 719-457-0820, confirmation code: 4235170.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, and YouTube.
Bristol-Myers Squibb Company
Ken Dominski, 609-252-5251
Lisa McCormick Lavery, 609-252-7602
John Elicker, 609-252-4611
Tim Power, 609-252-7509
Bill Szablewski, 609-252-5894
Source: Bristol-Myers Squibb Company